Filing Details
CorMedix Inc. (NASDAQ:CRMD) filed a Form 8-K with the Securities and Exchange Commission on July 01, 2026, disclosing a material event.
8k filedNASDAQ:CRMD
CorMedix Inc. (CRMD) Reports Material Event to SEC
Filing Details CorMedix Inc. (NASDAQ:CRMD) filed a Form 8-K with the Securities and Exchange Commission on July 01, 2026, disclosing a material event. Market Context CorMedix…
Market Context
CorMedix Inc.'s stock currently trades at $8.47 with a market capitalization of $924.2M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for CorMedix Inc.'s stock.
All SEC filings for CorMedix Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CRMD Stock Page
Frequently Asked Questions
Where can I read CRMD's SEC filings?
Browse all filings on our CRMD SEC filings page.
What types of SEC filings does CorMedix Inc. file?
Public companies like CorMedix Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.